Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial von Kalinsky, K., Diamond, J.R., Vahdat, L.T., Tolaney, S.M., Juric, D., O'Shaughnessy, J., Moroose, R.L., Mayer, I.A., Abramson, V.G., Goldenberg, D.M., Sharkey, R.M., Maliakal, P., Hong, Q., Goswami, T., Wegener, W.A., Bardia, A.

Volltext

Impact of Functional and/or Phenotypic PET Imaging on the Determination of Clinical Target Volumes of Vertebral Metastases Before Stereotactic Body Radiation Therapy Compared to MR... von Pichon, B, Supiot, S, Delpon, G, Ferrer, L, Rauscher, A, Leturnier, M, Libois, V, Goineau, A, Chauvet, A. Faivre, Baumgartner, P, Goldenberg, D.M, Sharkey, R, Barbet, J, Kraeber-Bodere, F, Mahe, M, Rousseau, C

Volltext

Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket tria... von Bardia, A., Messersmith, W.A., Kio, E.A., Berlin, J.D., Vahdat, L., Masters, G.A., Moroose, R., Santin, A.D., Kalinsky, K., Picozzi, V., O'Shaughnessy, J., Gray, J.E., Komiya, T., Lang, J.M., Chang, J.C., Starodub, A., Goldenberg, D.M., Sharkey, R.M., Maliakal, P., Hong, Q., Wegener, W.A., Goswami, T., Ocean, A.J.

Volltext

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer von Bardia, A., Tolaney, S.M., Punie, K., Loirat, D., Oliveira, M., Kalinsky, K., Zelnak, A., Aftimos, P., Dalenc, F., Sardesai, S., Hamilton, E., Sharma, P., Recalde, S., Gil, E.C., Traina, T., O’Shaughnessy, J., Cortes, J., Tsai, M., Vahdat, L., Diéras, V., Carey, L.A., Rugo, H.S., Goldenberg, D.M., Hong, Q., Olivo, M., Itri, L.M., Hurvitz, S.A.

Volltext

CD84 is a survival receptor for CLL cells von Binsky-Ehrenreich, I, Marom, A, Sobotta, M C, Shvidel, L, Berrebi, A, Hazan-Halevy, I, Kay, S, Aloshin, A, Sagi, I, Goldenberg, D M, Leng, L, Bucala, R, Herishanu, Y, Haran, M, Shachar, I

Volltext

THU0288 IMMU-115 (Humanized Anti-CD74 Antibody) for Subcutaneous (SC) Administration: A Phase Ib Study in Patients with Systemic Lupus Erythematosus (SLE) von Wallace, D.J., Weisman, M.H., Wegener, W.A., Horne, H., Goldenberg, D.M.

Volltext

The humanized anti-HLA-DR moAb, IMMU-114, depletes APCs and reduces alloreactive T cells: implications for preventing GVHD von Chen, X, Chang, C-H, Stein, R, Goldenberg, D M

Volltext

Red Marrow Radiation Dose Adjustment Using Plasma FLT3-L Cytokine Levels: Improved Correlations Between Hematologic Toxicity and Bone Marrow Dose for Radioimmunotherapy Patients von Siegel, Jeffry A, Yeldell, Dion, Goldenberg, David M, Stabin, Michael G, Sparks, Richard B, Sharkey, Robert M, Brenner, Arnold, Blumenthal, Rosalyn D

Volltext

Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer von Kraeber-Bodéré, F, Goldenberg, D M, Chatal, J F, Barbet, J

Volltext

Radiolabelled monoclonal antibodies in the treatment of metastatic cancer von Goldenberg, D M

Volltext

209 POSTER Cancer therapy with antibodies conjugated to radionuclides emitting low-energy electrons von Mattes, M.J., Michel, R.B., Goldenberg, D.M.

Volltext

Interferon-gamma upregulates MUC1 expression in haematopoietic and epithelial cancer cell lines, an effect associated with MUC1 mRNA induction von Reddy, P.K, Gold, D.V, Cardillo, T.M, Goldenberg, D.M, Li, H, Burton, J.D

Volltext

Colonic Tumor CEA, CSAp and MUC-1 Expression following Radioimmunotherapy or Chemotherapy von Modrak, D.E., Gold, D.V., Goldenberg, D.M., Blumenthal, R.D.

Volltext

Comparaison de l’immuno-TEP pré-ciblée (anti-ACE et peptide marqué au 68GA) à une imagerie conventionnelle et la TEP-FDG chez des patientes métastatiques d’un cancer du sein (CS)... von Rousseau, C., Rauscher, A., Faivre-Chauvet, A., Carlier, T., Ferrer, L., Baumgartner, P., Goldenberg, D.M., Sharkey, R.M., Barbet, J., Kraeber-Bodéré, F.

Volltext

Regulation of tumour drug delivery by blood flow chronobiology von Blumenthal, R.D, Osorio, L, Ochakovskaya, R, Ying, Z, Goldenberg, D.M

Volltext

Effect of tumor producing cytokines on bone marrow proliferation von Blumenthal, R.D., Reising, A., Goldenberg, D.M., intro by P. Rameshwar

Volltext

Chronotolerance of experimental radioimmunotherapy: clearance, toxicity, and maximal tolerated dose of 131I-anti-carcinoembryonic antigen (CEA) IgG as a function of time of day of... von Blumenthal, R.D, Reising, A, Lew, W, Dunn, R, Ying, Z, Goldenberg, D.M

Volltext

288 A trivalent bispecific fusion protein produced in myeloma cells for improved pretargeting and therapy of CEA-expressing cancers von Rossi, E., Losman, M.J., Cardillo, T.M., Sharkey, R.M., Karacay, H., McBride, W., Horak, I.D., Goldenberg, D.M., Chang, C.-H.

Volltext

299 Preclinical in vivo evaluation of a doxorubicin-antibody conjugate for treating multiple myeloma von Griffiths, G.L., Sapra, P., Pickett, J., Cardillo, T., Stein, R., Govindan, S.V., Sheerin, A., Damoci, C., Horak, I.D., Goldenberg, D.M.

Volltext